exa-cel
Vertex pharmaceuticals,CRISPR therapeutics AG
[]
vertex and crispr therapeutics present new data on more patients with longer follow-up treated with exagamglogene autotemcel (exa-cel) at the 2022 european hematology association (eha) congress 
Get the latest news and follow the coverage of latest general updates, politics, financial updates, sports and more from the top trusted sources.